Generex Biotechnology Corporation
GNBT · OTC
4/30/2021 | 1/31/2021 | 10/31/2020 | 7/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $8,485 | -$24,407 | -$10,989 | -$11,879 |
| Dep. & Amort. | $280 | $282 | $278 | $323 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $6,657 | $7,101 | $11,860 | $4,007 |
| Other Non-Cash | -$15,265 | $15,523 | -$3,707 | $6,476 |
| Operating Cash Flow | $577 | -$980 | -$1,336 | -$634 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $690 | $2,658 | $357 | $110 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $502 | $740 | $2,156 | $245 |
| Financing Cash Flow | $502 | $740 | $2,156 | $245 |
| Forex Effect | $0 | $0 | -$2 | -$12 |
| Net Chg. in Cash | $1,079 | -$238 | $818 | -$401 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $596 | $834 | $15 | $417 |
| End Cash | $1,675 | $596 | $834 | $15 |
| Free Cash Flow | $577 | -$980 | -$1,336 | -$634 |